Cryomass Technologies Inc.
CRYM
$0.0291
$0.00196.99%
| Weiss Ratings | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.47 | |||
| Price History | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.38% | |||
| 30-Day Total Return | 7.78% | |||
| 60-Day Total Return | 66.29% | |||
| 90-Day Total Return | 94.00% | |||
| Year to Date Total Return | 56.45% | |||
| 1-Year Total Return | -20.49% | |||
| 2-Year Total Return | -73.74% | |||
| 3-Year Total Return | -89.02% | |||
| 5-Year Total Return | -85.45% | |||
| 52-Week High % Change | -67.81% | |||
| 52-Week Low % Change | 81.33% | |||
| Price | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.08 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Oct 18, 2024 | |||
| 52-Week High Price (Date) | May 16, 2024 | |||
| Valuation | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.45M | |||
| Enterprise Value | 12.26M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | -44.52% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 272.00 | |||
| Price/Book (Q) | -0.68 | |||
| Enterprise Value/Revenue (TTM) | 324.45 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -2.70 | |||
| Enterprise Value/EBIT | -2.66 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 236.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 416 7208 | |||
| Address | 1001 Bannock Street Denver, CO 80204 | |||
| Website | cryomass.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -12,213.75% | |||
| Profit Margin | -23,326.98% | |||
| Management Effectiveness | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -262.09% | |||
| Return on Equity | -- | |||
| Income Statement | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 37.80K | |||
| Total Revenue (TTM) | 37.80K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 37.80K | |||
| EBITDA (TTM) | -4.55M | |||
| EBIT (TTM) | -4.62M | |||
| Net Income (TTM) | -8.82M | |||
| Net Income Avl. to Common (TTM) | -8.82M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 24.21% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 32.86% | |||
| Balance Sheet | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 183.40K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 296.30K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -9.44M | |||
| Current Ratio (Q) | 0.041 | |||
| Book Value Per Share (Q) | -$0.04 | |||
| Total Assets (Q) | 1.13M | |||
| Total Current Liabilities (Q) | 7.24M | |||
| Total Debt (Q) | 6.00M | |||
| Total Liabilities (Q) | 10.57M | |||
| Total Common Equity (Q) | -9.44M | |||
| Cash Flow | CRYM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -103.90K | |||
| Cash from Financing (TTM) | 1.42M | |||
| Net Change in Cash (TTM) | 173.90K | |||
| Levered Free Cash Flow (TTM) | 424.10K | |||
| Cash from Operations (TTM) | -1.14M | |||
